NTCOC
ICPT

Northern Trust Company of Connecticut’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Northern Trust Company of Connecticut’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-665
Closed -$46K – 2035
2013
Q3 		$46K Buy
+665
New +$32.8K ﹤0.01% 1920

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Northern Trust Company of Connecticut's ICPT Position: Q4 2013 in Review

Northern Trust Company of Connecticut sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2013, closing a stake of 665 shares — an estimated $46K sold.

Northern Trust Company of Connecticut first reported a position in ICPT in Q3 2013 and held it in 1 quarter. The position peaked at $46K in Q3 2013. 88 funds tracked by Wall St. Rank hold ICPT as of Q4 2013.

  • Northern Trust Company of Connecticut reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2013 after selling out during the quarter.
  • Northern Trust Company of Connecticut sold 665 Intercept Pharmaceuticals, Inc. shares in Q4 2013, an estimated $46K.
  • Northern Trust Company of Connecticut first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2013 and held it in 1 quarter.
  • Northern Trust Company of Connecticut's Intercept Pharmaceuticals, Inc. position peaked at $46K in Q3 2013.
  • 88 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2013.

Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.